Review of an article: Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. Jill J.F. Belch, MD, FRCP, John Dormandy, MD, FRCS, and the CASPAR Writing Committee, Dundee and London, United Kingdom (J Vasc Surg 2010;52:825-33).
Section of Vascular Surgery, Health Sciences Centre, St. Boniface General Hospital, Winnipeg, Manitoba, Canada. lthomson@sbgh.mb.ca
Lily
L
Thomson
D001241:Aspirin / Q000627:therapeutic use*; D019917:Blood Vessel Prosthesis Implantation; D005260:Female; D006801:Humans; D035002:Lower Extremity / Q000098:blood supply*; D008297:Male; D016491:Peripheral Vascular Diseases / Q000601:surgery*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives*; D014680:Veins / Q000637:transplantation*
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin